Pharmaceuticals and Healthcare Reports Focal Segmental Glomerulosclerosis (FSGS) Market

Focal Segmental Glomerulosclerosis (FSGS)
Market Size, Analysis and Pipeline Review
Report 2016
“Focal Segmental glomerulosclerosis is a rare
disease that attacks the kidney's filtering units
(glomeruli) causing serious scarring which leads to
permanent kidney damage and even failure.”
Summary
The Report provides an overview of the Focal Segmental Glomerulosclerosis (Genito Urinary System
And Sex Hormones) pipeline landscape.
Complete Report Available @ http://www.radiantinsights.com/research/focal-
segmental-glomerulosclerosis-fsgs-pipeline-review-h2-2016
Focal Segmental glomerulosclerosis is a rare disease that attacks the kidney's filtering units
(glomeruli) causing serious scarring which leads to permanent kidney damage and even failure.
Symptoms include proteinuria, edema, high cholesterol, high blood pressure and poor appetite. Risk
factors include infection, obesity, sickle cell disease and reflux nephropathy. Treatment includes
antibiotics, vitamin D supplements, and immunosuppressive drugs.
Report Highlights
Radiant Insights's Pharmaceutical and Healthcare latest pipeline guide Focal Segmental
Glomerulosclerosis - Pipeline Review, H2 2016, provides comprehensive information on the
therapeutics under development for Focal Segmental Glomerulosclerosis (Genito Urinary System
Follow Us: